The Prime 25 Healthcare Expertise Leaders of Massachusetts for 2023
The Healthcare Expertise Report is happy to announce The Prime 25 Healthcare Expertise Leaders of Massachusetts for 2023. Massachusetts is well-known as a frontrunner within the healthcare expertise area. Boston, particularly, has lengthy been a hotbed of analysis and innovation in medical and life sciences, and town is residence to a few of the prime analysis institutes and hospitals on the planet. In the meantime, the excessive density of visiting sufferers and healthcare professionals make the state a great place for healthcare startups. This yr’s awardees earned their locations on our listing because of their dedication to innovation and bettering well being outcomes for sufferers within the state and past throughout a wide range of specialties, from genomics to immuno-oncology, medical robotics, and ocular therapeutics, amongst many others.
A few of the distinguished leaders on this yr’s listing embrace Meghan Scanlon, Senior Vice President and President, Urology for Boston Scientific, who’s answerable for creating and bringing to market modern, industry-leading options for urological, urogynecological, and gynecological ailments. In the meantime, Jean-Paul Kress, CEO of MorphySys, has strategically repositioned the corporate from a number one antibody expertise supplier to a world, commercial-stage biopharmaceutical firm with a robust late-stage pipeline. And Elizabeth Haines, Vice President of Regulatory & Medical Affairs for Conformis, is answerable for creating and implementing methods to maximise course of effectivity and effectiveness, directing the worldwide regulatory staff’s annual budgets, investments, and monetary efficiency, and overseeing scientific operations.
This yr’s awardees lead from a variety of positions, from CEO and CTO to COO, President, and SVP. What they’ve in widespread is their dedication to revolutionizing the healthcare expertise area, delivering improvements to enhance the lives of clinicians and sufferers alike. Please be a part of us in celebrating The Prime 25 Healthcare Expertise Leaders of Massachusetts for 2023.
1. Sadik Kassim
Firm: Danaher Company
Title: Chief Expertise Officer (Genomic Medicines)
Sadik Kassim is a scientist and government with intensive expertise within the biotechnology {industry} with a particular concentrate on cell and gene remedy bioprocessing and translational analysis. At present, he serves as Chief Expertise Officer at Danaher with a concentrate on new genomic medicines. Most lately, he was Chief Expertise Officer at Vor Bio, the place he constructed the technical operations staff answerable for course of growth, analytical growth, provide chain, and manufacturing help of a CRISPR gene-edited HSPC product and oversaw the corporate’s CAR-T efforts. Previous to Vor, Sadik served as Govt Director at Kite Pharma and led the event of producing processes for autologous CAR-T and TCR-based cell therapies.
Because the Chief Scientific Officer at Mustang Bio, Kassim managed the foundational build-out of the corporate’s preclinical and manufacturing actions. Earlier in his profession, he was Head of Early Analytical Improvement for Novartis’ Cell and Gene Therapies Unit and labored on analysis groups on the Nationwide Most cancers Institute with Dr. Steven Rosenberg, the College of Pennsylvania Gene Remedy Program with Dr. Jim Wilson, and Johnson and Johnson’s Immunology Discovery group. Kassim and his groups have contributed to the profitable BLA and MAA purposes for 3 of the commercially obtainable CAR-T therapies: Kymriah®, Yescarta®, and Tecartus®. He earned his PhD in microbiology and immunology from Louisiana State College and his Bachelor of Science in cell and molecular biology from Tulane College.
2. Mark Cobbold
Firm: AstraZeneca
Title: Vice President Discovery and Head of Oncology Cell Remedy, Oncology R&D
Mark Cobbold, MD, PhD, leads AstraZeneca’s Discovery Staff and is targeted on immuno-oncology and antibody drug conjugates — from novel goal identification and validation to scientific candidate choice. This consists of preclinical predictive fashions to establish sufferers who’ve the next chance of benefitting from immuno-oncology remedies, giving AstraZeneca the most effective likelihood of discovering probably the most environment friendly routes to efficient medicines. A big piece of the staff’s analysis in immuno-oncology is on the potential of dwelling medication — oncolytic viruses and cell therapies — to amplify the physique’s personal skill to acknowledge and assault tumors, destroying the most cancers cells and, probably, reaching a treatment.
Dr. Cobbold is a scientific immunologist and physician-scientist who in his coaching specialised in managing sufferers with immunodeficiency. His analysis has targeted on translational immunology, which incorporates most cancers immunology and immunotherapy. His early work associated to human viral immunity and restoring antiviral immune responses via mobile immunotherapy. By way of his analysis, he developed a robust curiosity in tumor neoantigens — believed to play a dominant function within the immune system’s response to most cancers — and has contributed towards the invention of a novel class of tumor antigens.
Dr. Cobbold additionally serves as an Affiliate Professor of Medication at Harvard Medical Faculty and Massachusetts Basic Hospital Most cancers Middle. He has authored practically 50 peer-reviewed papers, co-founded six biotechnology firms, and has generated 20 patents. He lectures extensively on most cancers immunology and immunotherapy at conferences and seminars, and he’s a member of a number of scientific and medical societies together with the Broad Institute, American Affiliation for Most cancers Analysis, American Affiliation for Hematology, and the British Society for Immunology. He additionally serves on the U.Ok. Academy of Medical Sciences Mentoring committee. After incomes a bachelor’s diploma in immunology and a medical diploma from the College of Edinburgh, Dr. Cobbold earned a doctorate from the College of Birmingham (U.Ok.) in immunology/immunotherapy and accomplished postdoctoral coaching on the College of Birmingham and the College of Virginia.
3. Meghan Scanlon
Firm: Boston Scientific
Title: Senior Vice President and President, Urology
Meghan Scanlon is Boston Scientific’s Senior Vice President and President, Urology, a place she has held since February 2020. On this function, she is answerable for creating and bringing to market modern, industry-leading options for urological, urogynecological, and gynecological ailments. Previous to her present function, Scanlon served as VP and Basic Supervisor for the worldwide Urology and Pelvic Well being business group, with duty for overseeing the Stone, Prostate Well being, Prosthetic Urology, and Girls’s Well being franchises. She is a member of the World Council for Inclusion and serves as the manager sponsor for Boston Scientific’s PRIDE worker useful resource group, which is a community of LGBTQ+ staff and allies that fosters inclusiveness {and professional} achievement via company and group LGBTQ+ applications and initiatives.
Since becoming a member of Boston Scientific in 2014 as VP, World Advertising and marketing for Endoscopy, Scanlon has progressed via roles of accelerating duty in Urology and Pelvic Well being and Endoscopy, and performed a major function in driving and shaping the worldwide business group constructions and portfolio innovation methods for each companies. Previous to becoming a member of Boston Scientific, Scanlon spent practically 15 years in management roles inside the Johnson & Johnson medical machine enterprise and began her early profession as a design engineer at Gillette. She holds each an MBA and MSME from Massachusetts Institute of Expertise and a Bachelor of Science in mechanical engineering from Tufts College.
4. Eric Chenelle
Firm: Fast Micro BioSystems
Title: Product Supervisor, Consumables and Sterility
Eric Chenelle is the Undertaking Supervisor, Consumables and Sterility, for Fast Micro BioSystems, an modern life sciences expertise firm offering mission-critical automation options to facilitate the environment friendly manufacturing and quick, protected launch of healthcare merchandise corresponding to biologics, vaccines, cell and gene therapies, and sterile injectables. Fast’s Development Direct® platform automates and modernizes the antiquated, guide high quality management microbiology testing workflows used within the largest and most complicated pharmaceutical manufacturing operations throughout the globe. The Development Direct® platform brings the standard management lab to the manufacturing ground, unlocking the ability of in-line/at-the-line QC automation to ship sooner outcomes, larger accuracy, elevated operational effectivity, higher compliance with information integrity laws, and faster choice making that clients depend on to make sure protected and constant provide of essential healthcare merchandise.
Previous to Fast Micro BioSystems, Chenelle served as Meals Security and High quality Account Supervisor for MilliporeSigma. Earlier than that, he was a BioMonitoring Utility Specialist for the corporate. He obtained his begin with MilliporeSigma in 2014 as a Technical Assist Specialist. He has additionally been a co-owner of the Tyngsboro, MA/Nashua, NH Anytime Health since 2010. Chenelle earned his Bachelor of Arts in neuroscience and sociology from Bowdoin Faculty and is engaged on his MBA in advertising from Southern New Hampshire College.
5. Paul Gudonis
Firm: Myomo
Title: Chief Govt Officer
Paul Gudonis has served as Chief Govt Officer of Myomo since 2011, positioning the corporate because the chief in medical robotics to beat higher limb paralysis. He has pioneered new applied sciences and created new markets throughout his 40-year profession spanning biomedical units, robotics, software program, and telecommunications companies. From launching the primary cellphone service within the nation at AT&T to constructing the primary Web spine community at BBN right into a billion-dollar international companies supplier, he has grown venture-backed startup firms, led a number of publicly held companies, and expanded the FIRST Robotics program to document progress and profitability.
Gudonis has served as a board member of private and non-private firms, and as Chairman of the Massachusetts Excessive Tech Council. He’s a member of the Dean’s Advisory Council at his alma mater, Northwestern College’s McCormick Faculty of Engineering, the place he earned his diploma in electrical engineering. On the college, he’s a member of the Biomedical Engineering Division council, an {industry} advisor to the NUvention medical machine innovation program, and advises a student-led startup, Design for America, which is increasing to school campuses nationwide to develop entrepreneurial options for native nonprofits. He additionally earned his MBA from Harvard College.
6. Jean-Paul Kress
Firm: MorphoSys
Title: Chief Govt Officer
As a skilled doctor, Jean-Paul Kress has devoted his profession to bringing transformative medicines to sufferers. Since becoming a member of MorphoSys as Chief Govt Officer in September 2019, he has strategically repositioned the corporate from a number one antibody expertise supplier to a world, commercial-stage biopharmaceutical firm with a robust late-stage pipeline. As a part of this evolution, the corporate launched its first drugs within the U.S. — an immunotherapy for an aggressive type of blood most cancers — and considerably enriched its pipeline via the acquisition of Constellation Prescription drugs in 2021. Along with his work at MorphoSys, Kress serves as chair of the board of administrators on the listed firm ERYTECH Pharma.
Previous to MorphoSys, Kress was CEO of Syntimmune, the place he oversaw the corporate’s transformation to a late-stage growth immunology firm, leading to its acquisition by Alexion. He held a number of senior management roles at pharmaceutical firms, together with EVP, President of Worldwide and Head of World Therapeutic Operations at Biogen, and SVP, Head of North America at Sanofi Genzyme, the place he was instrumental in launching Dupilumab, the primary biologic agent accredited in atopic dermatitis. Beforehand, he was President and CEO of Sanofi Pasteur MSD and held management positions at Gilead, AbbVie, and Eli Lilly and Firm. He additionally served on Sarepta Therapeutics’ Board of Administrators. Kress acquired an MD from Faculté Necker-Enfants Malades in Paris, and graduate and postgraduate levels in biochemistry and in molecular and mobile pharmacology from Ecole Normale Supérieure in Paris.
7. Gabriele Brambilla
Firm: Alira Well being
Title: Chief Govt Officer
Gabriele Brambilla is the Chief Govt Officer of Alira Well being, a world healthcare agency whose mission is to humanize healthcare and life sciences in partnership with sufferers. From growth to medical care, Alira enhances the experience of its Pharma, Biotech, and MedTech shoppers with a full spectrum of companies throughout their whole options lifecycle, together with scientific operations, real-world proof, and patient-centric expertise choices. Alira’s built-in and multidisciplinary staff of greater than 600 scientists, strategists, economists, clinicians, and biostatisticians collaborate throughout the corporate’s North American, European, and Asian workplaces and advise 80% of the highest 50 MedTech firms and 75% of the highest 50 Pharma firms.
Brambilla is captivated with healthcare innovation. Along with his appointment as Alira Well being CEO in 2014, he serves on the board of administrators for the modern start-ups EnlightenVue, WoundForce, Firefly, and Computational Life. In 2018, he co-founded the MetroWest Life Sciences Community to develop collaboration, innovation, and entrepreneurship in Boston’s MetroWest life sciences ecosystem. Brambilla is an everyday participant in international occasions as a moderator, speaker, and panelist. He earned his MBA in finance from SDA Bocconi in Milan, his Grasp in Worldwide Affairs from ISPI Milano, and his Bachelor of Arts in political science from the Università di Pavia, additionally in Milan.
8. Elizabeth Haines
Firm: Conformis
Title: Vice President, Regulatory & Medical Affairs
Elizabeth Haines has served as Vice President, Regulatory & Medical Affairs for Conformis since September 2022. On this function, a part of the Govt Management Staff, she is answerable for creating and implementing methods to maximise course of effectivity and effectiveness, directing the worldwide regulatory staff’s annual budgets, investments, and monetary efficiency, and overseeing scientific operations. Haines has greater than 17 years of expertise in medical machine and life sciences regulatory affairs. Instantly previous to becoming a member of Conformis, Haines served as Senior Director, Regulatory Affairs at ZOLL Medical Company from 2018-2022 within the resuscitation & circulation divisions. At ZOLL, she was the worldwide level of contact for all interactions with regulatory authorities, driving the implementation of regulatory KPIs to help organizational expansions in each divisions, and transitioning the group from a main 510(ok) group to a Class III PMA pushed group.
Haines served as Senior Supervisor, Regulatory Affairs at Straumann Group USA. There, she steered the regulatory sources of the enterprise models to confirm well timed product registrations and devised regulatory methods for brand spanking new product introductions and product modifications. Previous to that, she served as Senior Supervisor, Regulatory Affairs at Sekisui Diagnostics, LLC. On this function, she represented Regulatory Affairs on designated product/challenge groups to develop regulatory methods and help cross-functional collaboration. Haines served as Senior Supervisor, Regulatory Affairs at Ocular Therapeutix, Inc., in Bedford, Massachusetts. At Ocular, she developed and applied regulatory methods to facilitate the scientific execution and commercialization of merchandise worldwide in addition to transitioning the corporate from medical machine to a med machine and pharmaceutical firm. She earned a Bachelor of Science in well being administration at Northeastern College, a number of government certificates in technique and management at Cornell College, and has Six Sigma Yellow Belt and Lean Chief designations.
9. Jonathan Go
Firm: iCAD
Title: Chief Expertise Officer
Jonathan Go serves as Chief Expertise Officer for iCAD. He brings greater than twenty 5 years of software program growth expertise within the medical {industry} to the corporate. Previous to becoming a member of iCAD, Go served as Vice President of Engineering at Merge eMed, a supplier of RIS/PACS options for imaging facilities, specialty practices, and hospitals. At Merge eMed, he was answerable for software program growth, product administration, testing, system integration, and technical help for all of eMed’s merchandise.
Earlier than becoming a member of Merge eMed, Go was Director of Engineering at Cedara Software program in Toronto. Cedara Software program is targeted on the event of customized engineered software program purposes and growth instruments for medical imaging OEMs. At Cedara, Go constructed the workstation program, creating a number of specialty workstations which have been adopted by a lot of OEM companions. He earned a Grasp of Science in electrical engineering and biomedical engineering and a Bachelor of Science in electrical engineering from the College of Michigan.
10. Sanjiv Patel
Firm: Relay Therapeutics
Title: President and Chief Govt Officer
Sanjiv Patel brings greater than 20 years of life sciences {industry} expertise to his function as President and Chief Govt Officer of Relay Therapeutics. Previous to Relay, Patel was at Allergan for greater than a decade and performed a key half within the firm’s sustained progress and worth creation over that interval. He held roles of elevated duty, together with main international strategic advertising for all franchises and basic administration of Allergan’s quickest progress geographic area, the rising markets. Patel was most lately a part of Allergan’s government staff as chief technique officer, the place he was on the heart of a few of the {industry}’s largest transactions. His work with the senior management staff of Allergan outlined its long-term goals and technique, together with divestment and integration planning actions.
Previous to Allergan, Patel was a administration guide at Boston Consulting Group in London, and he began his profession as a surgeon within the U.Ok.’s Nationwide Well being Service. Patel holds an MBA from INSEAD, an MBBS from the College of London, and a Grasp of Arts in neurosciences from Cambridge College.
11. Natan Linder
Firm: Tulip
Title: Co-Founder and Chief Govt Officer
Natan Linder is the Co-Founder and Chief Govt Officer of Tulip, a producing expertise firm and World Financial Discussion board Tech Pioneer. Tulip gives a cloud IoT software program platform that’s deployed at a few of the largest international producers, serving to clients drive their Business 4.0 and Digital Transformation initiatives. Linder can be Co-Founder and Chairman of Formlabs, a pioneer and {industry} chief in skilled desktop 3D printing. He has over 15 years of expertise as a frontrunner at firms like Samsung, Solar Microsystems, and Rethink Robotics and holds a depth of experience in pc science, product design, and entrepreneurship.
Previously, Linder was Co-Founder and Basic Supervisor of Samsung Digital’s R&D Middle in Israel, spearheading the group’s innovation efforts in cell and transport a number of merchandise to the worldwide market. He was Entrepreneur-in-Residence with Jerusalem Enterprise Companions, a number one Israeli enterprise capital agency. He holds a PhD from the MIT Media Lab’s Fluid Interfaces Group and an MSc in Media Arts and Sciences from MIT. His work goals to fuse design and engineering to create novel human experiences.
12. Andrey Zarur
Firm: Greenlight Biosciences Inc.
Title: Co-Founder, President, and Chief Govt Officer
Andrey Zarur is a Co-Founder, President, and Chief Govt Officer of GreenLight Biosciences. The corporate was based in 2008 to develop superior organic options to beat a few of the greatest challenges confronted by the human race, together with sustainable meals manufacturing, response and preparedness for pandemics, and international entry to efficient human well being.
Dr. Zarur can be a Co-Founder and was Chairman of the Board of Stable Biosciences, Inc., a gene remedy firm concentrating on Duchenne Muscular Dystrophy. As well as, he’s a Co-Founder and Chairman of the Board at Lumicell Surgical, an oncology firm delivering superior imaging options to most cancers surgical procedure, and has been a co-founder and senior government in additional than a dozen firms within the healthcare and clear vitality sectors. Previous to beginning GreenLight, he was Managing Companion at Kodiak Enterprise Companions, an early-stage, technology-driven enterprise fund based mostly in Boston.
Dr. Zarur carried out graduate doctoral research in chemical and biomedical engineering on the Massachusetts Institute of Expertise, and immunology at Harvard-MIT. He’s a steadily invited speaker at scientific and commerce conferences, has authored quite a lot of landmark peer-reviewed articles in prestigious scientific journals, holds greater than 100 provisional and issued patents, and has been frequently quoted in worldwide media on the pandemic and RNA vaccines, together with latest opinion items in Fortune and Stat in addition to quotes within the Monetary Instances, Traders Enterprise Day by day, Wired, Enterprise Insider, and CNBC.
13. Gilmore O’Neill
Firm: Editas Medication
Title: President and Chief Govt Officer
Gilmore O’Neill is President and Chief Govt Officer of Editas Medication and a member of the Editas Board of Administrators. He joined Editas Medication in June 2022. O’Neill brings to Editas greater than 20 years of expertise in genetic drugs, neurobiology, and scientific growth. He additionally has a observe document of driving and main a number of of biotech’s most profitable scientific applications and reaching advertising approvals for a number of medicines, together with Amondys®, Vyondys®, Spinraza®, Plegridy®, and Tecfidera®.
O’Neill most lately served as Govt Vice President of R&D and Chief Medical Officer at Sarepta Therapeutics. Throughout his tenure at Sarepta, he led the R&D management staff accountable throughout the worth chain from creating and driving discovery, preclinical and scientific growth, and international regulatory technique of its RNA and gene therapeutic portfolio via to Medical Affairs help of the marketed merchandise. Previous to that, O’Neill held a number of management roles at Biogen over a 15-year interval, most lately serving as Senior Vice President answerable for all late-stage scientific growth. Throughout his tenure at Biogen, he oversaw growth applications for uncommon illness, gene and cell remedy, neuromuscular illness, ache, a number of sclerosis, acute neurology, motion problems, and Alzheimer’s illness.
O’Neill presently serves on the board of administrators at UNITY Biotechnology, Inc., a biotechnology firm creating therapeutics to gradual, halt, or reverse ailments of getting old, and at Aptinyx, Inc., a biotechnology firm creating therapies for the therapy of mind and nervous system problems. O’Neill acquired a Bachelor of Medication from College Faculty Dublin, a Grasp of Medical Sciences from Harvard College, and accomplished his Neurology Residency coaching at Massachusetts Basic Hospital. He’s licensed to apply drugs within the state of Massachusetts.
14. Paul Bolno
Firm: Wave Life Sciences
Title: President and Chief Govt Officer
Dr. Paul Bolno has served as President and Chief Govt Officer of Wave Life Sciences since 2013 and oversaw the corporate’s preliminary public providing in 2015. Throughout his tenure as President and CEO, Dr. Bolno has grown Wave into a totally built-in clinical-stage genetic medicines firm, overseen the event of the corporate’s proprietary stereopure oligonucleotide discovery and drug growth platform, and constructed a broad pipeline of preclinical and scientific applications supported by scalable, in-house manufacturing capabilities. Along with Dr. Bolno’s present function at Wave, he’s on the board of administrators for SQZ Biotech and serves as Chairman of the Scientific Advisory Group for the Nucleic Acid Remedy Accelerator (NATA) within the U.Ok.
Previous to becoming a member of Wave, Dr. Bolno was Vice President, Worldwide Enterprise Improvement — Head of Asia BD and Investments, in addition to Head of World Neuroscience BD, at GlaxoSmithKline (GSK). He additionally served as a Director of Glaxo Wellcome Manufacturing, Pte Ltd. in Singapore. Dr. Bolno joined GSK as Vice President, Enterprise Improvement for the Oncology Enterprise Unit, the place he helped set up GSK’s international oncology enterprise and served as a member of the Oncology Govt Staff, Oncology Industrial Board, and Most cancers Analysis Govt Staff. Previous to GSK, he served as Director of Analysis at Two River LLC, a healthcare personal fairness agency. Dr. Bolno earned his MD from MCP-Hahnemann Faculty of Medication and an MBA from Drexel College. He was a basic surgical procedure resident and cardiothoracic surgical procedure postdoctoral analysis fellow at Drexel College Faculty of Medication.
15. Antony Mattessich
Firm: Ocular Therapeutix, Inc.
Title: President and Chief Govt Officer
Antony Mattessich joined Ocular Therapeutix, Inc. as Chief Govt Officer in August of 2017. Ocular is a biopharmaceutical firm targeted on the formulation, growth, and commercialization of modern therapies for ailments and circumstances of the attention utilizing its proprietary bioresorbable hydrogel-based formulation expertise. Its strong product pipeline positions Ocular to turn out to be a frontrunner within the ophthalmic area as a result of its skill to create drug supply options that cut back the complexity and burden of the present normal of care by creating sustained launch options.
Previous to becoming a member of Ocular, Mattessich was Managing Director of Mundipharma Worldwide based mostly in Cambridge, England. Earlier than that, he ran the U.S. respiratory, dermatology, and pediatrics group at Novartis. He additionally held a number of positions at Bristol-Myers Squibb, amongst them, Managing Director roles in Malaysia/Singapore and The Netherlands, and Head of Operations for the Worldwide Medicines Group. Mattessich holds a Masters in Worldwide Affairs from Columbia College and a Bachelor of Arts from the College of California at Berkeley.
16. Anna Protopapas
Firm: Mersana Therapeutics
Title: President and Chief Govt Officer
Anna Protopapas joined Mersana as President and Chief Govt Officer in March 2015, bringing a considerable observe document of government management and enterprise expertise within the biotech {industry}. Previous to Mersana, Protopapas was President of Millennium, the place she led Takeda Pharmaceutical Co.’s $1.3 billion oncology enterprise. She additionally served because the Govt Vice President of World Enterprise Improvement for Takeda Prescription drugs, the place she oversaw international acquisitions, partnering, licensing, and enterprise investing. On this function, she led Takeda’s $12 billion acquisition of Nycomed, a important step within the firm’s globalization. Protopapas was a member of Takeda’s government committee and was elected a company officer in 2011.
Earlier in her profession, Protopapas served as an government officer at Millennium Prescription drugs and served in varied senior management positions, enjoying an integral function within the firm’s transformation from a genomics start-up to a totally built-in oncology chief. She was instrumental within the sale of Millennium to Takeda for $8.8 billion. Protopapas serves because the Chairperson of the board of administrators of Nuvalent, Inc. She beforehand served on the boards of administrators of Ariad Prescription drugs from Might 2015 to February 2017, when it was bought to Takeda for $5.2 billion; Bioverativ from January 2017 to January 2018, when it was bought to Sanofi for $11.6 billion; and Dicerna Prescription drugs from January 2019 to June 2021. Protopapas earned her MBA from Stanford Graduate Faculty of Enterprise, her Grasp of Science in chemical engineering from the Massachusetts Institute of Expertise, and her Bachelor of Science in science and engineering from Princeton College.
17. Martha Rook
Firm: insitro
Title: Chief Technical Operations Officer
Martha Rook presently serves as Chief Technical Operations Officer for insitro. Insitro is a data-driven drug discovery and growth firm that leverages machine studying and high-throughput biology to remodel the way in which medicines are created to assist sufferers. Rook has greater than 20 years of educational and {industry} expertise in molecular biology, diagnostics growth, biologics course of growth, and cell and gene remedy manufacturing.
Previous to becoming a member of insitro, Rook was Chief Technical Operations Officer for Sigilon Therapeutics, Inc., the place she was answerable for the Analytics, Manufacturing, Provide Chain, and High quality organizations. Earlier than that, she spent greater than 13 years at MilliporeSigma and held a wide range of roles, in the end serving as Vice President and Head of the Gene Enhancing & Novel Modalities Enterprise, the place she led a staff creating and offering instruments and companies for cell and gene therapies from discovery to manufacturing. Rook acquired her PhD in biochemistry from the Massachusetts Institute of Expertise and holds a Bachelor of Science in chemistry from Texas A&M College. She pursued post-doctoral research in neuroscience as a Lefler Fellow at Harvard Medical Faculty’s Middle for Neurologic Ailments.
18. Lisa Wyman
Firm: Generate Biomedicines, Inc.
Title: Senior Vice President of Technical Operations
Lisa Wyman is head of technical operations at Generate Biomedicines, main multi-faceted groups throughout CMC, technical growth, high quality, and provide operations to construct out Generate’s international technical operations group to help the corporate’s pursuit of a broad portfolio of medicines.
Most lately, Wyman served because the Senior Vice President of Technical Operations and High quality at Acceleron, the place she helped to remodel the enterprise from a analysis and development-focused firm to a totally built-in biotech, which led to the eventual sale of the corporate to Merck & Co. in 2021 for over $11 billion. She led the CMC technique for the accelerated growth of sotatercept for pulmonary arterial hypertension and supported the launch of Acceleron’s first business product Reblozyl. Wyman has expertise working with international regulatory businesses, GxP high quality administration techniques, and scaling up manufacturing for clinical-stage firms.
Earlier than becoming a member of Acceleron, Wyman had roles of accelerating duty at Mersana Therapeutics, Shire, and Boston Scientific. She has acquired a number of awards, together with a Life Sciences Voice Prime Business Chief, Development of Girls in Compliance Mentor of the 12 months Finalist, Boston Enterprise Journal’s 40 Beneath 40 Winner, and Management Engineering and Plant Engineering Journal’s Engineering Chief. Wyman earned her Grasp of Science in engineering administration from Tufts College and graduated from Ithaca Faculty with a bachelor’s diploma in biology.
19. Sam Tran
Firm: Gritstone bio
Title: Vice President, Info Expertise
Sam Tran is the Vice President of Info Expertise at Gritstone bio. He first joined the corporate in 2018 as Senior Director of Info Expertise. Gritstone bio brings collectively a bunch of distinguished scientific founders and advisors, a extremely skilled and various management staff, and a seasoned and profitable board of administrators to deal with elementary challenges on the intersection of most cancers genomics, immunotherapy, and different precision remedy areas, particularly in COVID-19 and HIV.
With its distinctive strategy to immuno-oncology and infectious ailments, Gritstone bio seeks to generate a therapeutic immune response by leveraging insights into the immune system’s skill to acknowledge and destroy diseased cells by concentrating on choose antigens. It began with a concentrate on tumor-specific neoantigens and extra lately prolonged its applications to incorporate viral antigens displayed on the floor of virus-infected cells. The biology underlying immune system recognition of targets on the floor of irregular cells is widespread to each antitumor and antiviral immunity. Consequently, the corporate believes that activating and directing the immune system to those targets may provide an essential alternative to increase the advantages of immunotherapy for extra sufferers.
Beforehand, Tran was a Director and Head of Informatics and IT at Syros Prescription drugs, and earlier than that Director of IT Operations at Basis Medication. Earlier in his profession he labored with CombinatoRx as a community administrator. Tran earned a Bachelor of Science in Enterprise Administration in MIS & administration from the College of Massachusetts Lowell.
20. Andrew Ashe
Firm: Verve Therapeutics
Title: President, Chief Working Officer, and Basic Counsel
Andrew Ashe is President, Chief Working Officer, and Basic Counsel for Verve Therapeutics, a clinical-stage biotechnology firm created with a singular focus: to guard the world from coronary heart illness. Based by world-leading consultants in cardiovascular drugs, human genetics, and gene enhancing, the corporate goals to develop transformative, once-and-done therapies for coronary coronary heart illness. Ashe is an achieved biotech government with over 20 years of expertise in operations and authorized administration. Previous to becoming a member of Verve, he served as a senior government and basic counsel for a number of biotech firms, together with Utilized Genetic Applied sciences Company and Dyax Corp. Throughout his tenure at Dyax, Ashe managed all authorized and administrative capabilities throughout a interval of progress by which market capitalization elevated from $180 million to $6 billion.
Whereas at Dyax, Ashe additionally established greater than 75 revenue-generating collaborations with biotech and pharma firms in the USA, Europe, India, Australia, and Japan. Dyax was acquired in 2016. Beforehand, Ashe was a member of the enterprise regulation practices at Prince Lobel Tye LLP and Nutter, McClennen & Fish LLP. Previous to attending regulation college, he served as a buying and selling specialist and senior analyst on the American and New York Inventory Exchanges. He holds a JD from the George Washington College Faculty of Legislation and a Bachelor of Arts in finance from the Isenberg Faculty of Administration on the College of Massachusetts.
21. Yaron Rachmany
Firm: Variantyx
Title: Chief Working Officer
Yaron Rachmany presently serves as Chief Working Officer for Variantyx and oversees the corporate’s IT techniques and enterprise processes. Variantyx is a technology-driven precision drugs firm offering state-of-the-art diagnostic options for the uncommon genetic problems and reproductive genetics markets, and therapy optimization in oncology. The corporate’s distinctive, complete testing platform makes use of entire genome sequencing to establish all main genetic modifications from a single pattern. The outcomes empower sufferers and suppliers with info that may quickly finish the difficult diagnostic search, optimize therapy, and enhance high quality of life.
Previous to becoming a member of Variantyx, Rachmany served as Director of Methods Operations and as Director of IT Purposes at Semtech Company. Earlier than that, he was Vice President of Info Methods with Credorax and held senior info techniques positions with Microsemi, Intel, and ECI Telecom. Rachmany holds a Grasp of Science and a Bachelor of Science in industrial engineering and administration (specialised in info techniques) from Ben Gurion College in Israel.
22. Andrew Miller
Firm: Karuna Therapeutics
Title: Founder and Chief Working Officer
Dr. Andrew Miller is a Founder and the Chief Working Officer of Karuna Therapeutics, a clinical-stage firm concentrating on muscarinic receptors for the therapy of psychosis and cognition with a concentrate on schizophrenia and Alzheimer’s illness. Dr. Miller is the lead inventor of Karuna’s KarXT platform and served as CEO of Karuna from 2016 to 2018. He served as a member of Karuna’s board of administrators from April 2012 to March 2019. From August 2008 to July 2016, Dr. Miller held a number of positions at PureTech Well being plc, final serving as a Vice President, Enterprise Companion, and served as COO of Tal Medical and because the appearing COO of Entrega, Inc. He’s presently a member of the board of administrators of Entrega.
Dr. Miller acquired his bachelor’s diploma in chemical engineering from the College of Illinois with highest honors and his PhD in chemical engineering from the Massachusetts Institute of Expertise, and acquired the MIT Presidential fellow and Nationwide Protection Science and Engineering Graduate fellowship awards. In 2016, Dr. Miller was named one of many prime 40 innovators beneath 40 by MedTech Boston.
23. Slava Akmaev
Firm: Scipher Medication
Title: Chief Expertise Officer
Slava Akmaev presently serves because the Chief Expertise Officer for Scipher Medication, a precision immunology firm matching every affected person with their handiest remedy. Dr. Akmaev has been named one of many Prime 100 AI Leaders in Drug Discovery and Superior Healthcare and is a frequent speaker at a few of the most prolific {industry} occasions. He’s the inventor of a number of issued and pending patent purposes and has printed greater than 20 peer-reviewed articles in computational biology, synthetic intelligence, and molecular biology.
Dr. Akmaev’s expertise consists of creating data-driven applied sciences for goal discovery and precision drugs and launching a number of business diagnostic merchandise at Berg and GNS Healthcare. He began his profession working for Genzyme Genetics, the place he developed novel statistical approaches for high-throughput “omics” information. Dr. Akmaev holds a PhD and a Grasp of Science in utilized arithmetic from the College of Colorado at Boulder.
24. Peter Olagunju
Firm: TCR² Therapeutics Inc.
Title: Chief Working Officer
Peter Olagunju presently serves as Chief Working Officer of TCR² Therapeutics, Inc. is a clinical-stage cell remedy firm creating a pipeline of novel T cell therapies for sufferers affected by strong tumors. The corporate is targeted on the invention and growth of product candidates in opposition to novel and sophisticated targets using its proprietary T cell receptor (TCR) Fusion Assemble T cells (TRuC®-T cells). He brings over 20 years of expertise in cell and gene remedy, scientific growth, program administration, manufacturing and technical operations. Previous to becoming a member of the Firm, he was Senior Vice President of Technical Operations at FerGene Inc., the place he led the technical operations perform for the commercialization of a gene remedy for bladder most cancers.
Olagunju joined TCR² in 2021 as Chief Technical Officer. Earlier than that, he served as Vice President of World Affected person Operations at bluebird bio, Inc., the place he held a number of roles of accelerating duty and was this system lead and useful head of producing supporting the European approval for ZYNTEGLO®, a transformational gene remedy for transfusion dependent thalassemia (TDT). Earlier in his profession, he held senior positions in Industrial Technical Operations and served because the Head of High quality at Dendreon Corp. and ZymoGenetics, Inc. Olagunju holds an MBA from the College of Washington and a Bachelor of Science in biology from the College of Illinois at Urbana–Champaign.
25. Marc Blaustein
Firm: Finch Therapeutics Group
Title: Chief Working Officer and Principal Monetary Officer
Marc Blaustein presently serves as Chief Working Officer and Principal Monetary Officer for Finch Therapeutics Group, which has a portfolio of microbiome belongings together with CP101, a late-stage, investigational, orally administered microbiome candidate with constructive scientific information from a Section 2 randomized, placebo-controlled trial and a Section 2 open-label trial in recurrent C. Blaustein is a seasoned biopharmaceutical government with greater than 20 years of expertise constructing and main firms and demanding enterprise capabilities together with operations, enterprise growth, program administration, and manufacturing.
Previous to becoming a member of Finch, Blaustein consulted because the Head of Enterprise Improvement for Information Therapeutics, which was acquired by Beam Therapeutics in 2021. Earlier than that, he was the Chief Govt Officer of NED Biosystems and Co-Founder and CEO of Akashi Therapeutics. Previous to founding Akashi, he served in varied management positions throughout a number of biotechnology firms, together with Senior Vice President of Manufacturing, Course of, and Industrial Operations at Dyax Corp. (now Takeda), the place he led the event of Kalbitor®. Earlier than Dyax, Blaustein held enterprise growth and administration roles at Alkermes, the place he initiated and led the event program for Vivitrol®. And previous to Alkermes, he labored in enterprise growth at Genetics Institute (now Pfizer). He started his profession in administration consulting, first at Mercer Administration Consulting, after which as a founding associate of Northbridge Consulting. Blaustein acquired his Grasp of Public Coverage from Harvard College and his Bachelor of Arts in biology from the College of Pennsylvania. He’s additionally a Chartered Monetary Analyst (CFA) charterholder.
